Rafii, Michael S.
Funding for this research was provided by:
National Institute on Aging (1R01AG047922)
Article History
First Online: 7 June 2016
Compliance with Ethical Standards
:
: There was no specific funding used to assist with the preparation of this review.
: MSR is funded by an NIH R01 as principal investigator for a multicenter clinical trial of ACI-24 in Down syndrome (AG047922-01). He has also received research grants from Elan Corporation (Dublin, Ireland), Hoffmann-La Roche (Basel, Switzerland) and Janssen Pharmaceuticals (Titusville, New Jersey). He was a site investigator for the ELND005 study as well as the RG1662 phase I and phase II studies.